Postpartum Hemorrhage (PPH) Treatment Devices Market: Current Developments and Expected Advancements


Posted June 6, 2016 by ranutmr

Postpartum hemorrhage (PPH) can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery.

 
The global postpartum hemorrhage treatment devices market is progressing at a CAGR of 4.9% within a forecast period of 2015 to 2023. Owing to this positive growth rate, the market is expected to reach US$926.1 mn before the end of 2023. The global postpartum hemorrhage treatment devices market was recorded at US$604.4 mn in 2014, according to a research report released by Transparency Market Research. The report, titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023,” is an all-inclusive analytical guideline for any client who wishes to create a stronger business position within this market.

A patient is diagnosed with postpartum hemorrhage only after there has been a loss of at least 500 ml of blood after a vaginal delivery, and at least 1,000 ml in the case of cesarean delivery, both within a certain time frame. If the mother has lost the specified amount of blood within 24 hours of delivery, it is known as primary PPH, while it is classified as secondary PPH if she bleeds after 24 hours of delivery.

Read More: http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html

According to the report, the global postpartum hemorrhage treatment devices market is primarily being driven by the rising cases of PPH across the world. This market is also benefitting from the increased investment efforts taken up by multiple governments, along with the steadily growing education programs and awareness towards the complications caused by PPH and the various treatment solutions available.

The global postpartum hemorrhage treatment devices market is currently, however, still facing the major hindrance of a very low awareness rate. This applies especially to developing economies where the market is stifled by a high rate of social rejection rates related to any modern and unconventional treatments and preventive devices.

The report divides the global postpartum hemorrhage treatment devices market on the basis of products into uterine balloon tamponade, Uniject prefilled infection systems, and non-pneumatic anti-shock garments. The segment of uterine balloon tamponades led the market in 2014 owing to low cost and a higher availability rate. The segment of Uniject prefilled injection systems is exhibiting the fastest growth rate for the report’s forecast period.

Geographically, the global postpartum hemorrhage treatment devices market was led by North America in 2014 owing to several factors. These include the rising number of PPH cases and related maternal mortality rate along with the higher availability of modern and advanced healthcare. At the same time, Asia Pacific is expected to report the fastest growth rate due to a rapidly increasing awareness rate and major improvements in healthcare infrastructure. Another factor to consider, especially for developing economies such as Hong Kong, China, and India, is the high rate of anemia among women. More than 60% of the average population of women is suffering from anemia, which is one of the leading causes of PPH.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164

The key players in the global postpartum hemorrhage treatment devices market are discussed in detail within the report. These include Zoex, Utah Medical Products, Inc., Teleflex Incorporated, Program for Appropriate Technology in Health (PATH), C. R. Bard, Inc., Cook Medical, Inc., Bactiguard AB, and 3rd Stone Design, Inc.

Key Segments of the Global Postpartum Hemorrhage Treatment Devices Market
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
•Non-pneumatic Anti-shock Garment (NASG)
•Uniject Prefilled Injection System
•Uterine Balloon Tamponade
oFoley Catheters
oCondom Catheters
oOthers

Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
•North America
oU.S.
oCanada
•Europe
oGermany
oU.K.
oRest of Europe
•Asia Pacific
oJapan
oChina
oRest of Asia Pacific
•Latin America (LATAM)
•Middle East & North Africa (MENA)
•Rest of the World


About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Marketing , Medical
Tags global postpartum hemorrhage treatment devices market , postpartum hemorrhage treatment devices industry analysis , postpartum hemorrhage treatment devices market , postpartum hemorrhage treatment devices market research report
Last Updated June 6, 2016